Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines
Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines
复制标题
DOI：
10.6004/jnccn.2022.0016
复制
发表时间：
2022-03-01
影响因子：
13.4
通讯作者：
Darlow, Susan D.
中科院分区：
文献类型：
--
作者：
Caudell, Jimmy J.;Gillison, Maura L.;Darlow, Susan D.
NCCN头颈部癌症指南涉及口腔（包括唇粘膜）、咽、喉和鼻窦中发生的肿瘤。隐匿性原发癌，唾液腺癌，粘膜黑色素瘤（MM）也解决了。疾病的具体部位、分期和病理结果指导治疗（例如，适当的外科手术、放射靶点、放射剂量和分次、全身治疗的适应症）。NCCN头颈部癌症专家组至少每年召开一次会议，审查其机构内审查人员的意见，检查出版物和摘要中的相关新数据，并重新评估和更新其建议。这些NCCN指南见解总结了该小组关于HPV阳性口咽癌管理的最新建议以及该领域正在进行的研究。
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.